UBS Group AG - REDHILL BIOPHARMA LTD ownership

REDHILL BIOPHARMA LTD's ticker is RDHL and the CUSIP is 757468103. A total of 45 filers reported holding REDHILL BIOPHARMA LTD in Q3 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of REDHILL BIOPHARMA LTD
ValueSharesWeighting
Q4 2022$405
-86.5%
2,891
-59.3%
0.00%
Q3 2022$3,000
-82.4%
7,097
-62.6%
0.00%
Q2 2022$17,000
-61.4%
18,957
+8.4%
0.00%
Q1 2022$44,000
-92.9%
17,484
-92.7%
0.00%
Q4 2021$622,000
+34.6%
240,852
+138.9%
0.00%
Q3 2021$462,000
-28.4%
100,803
+7.5%
0.00%
Q2 2021$645,000
+125.5%
93,802
+140.2%
0.00%
Q1 2021$286,000
-28.7%
39,051
-21.4%
0.00%
Q4 2020$401,000
+629.1%
49,701
+819.7%
0.00%
Q3 2020$55,000
+243.8%
5,404
+126.0%
0.00%
Q2 2020$16,000
+45.5%
2,3910.0%0.00%
Q1 2020$11,000
-26.7%
2,3910.0%0.00%
Q4 2019$15,000
-11.8%
2,3910.0%0.00%
Q3 2019$17,000
-26.1%
2,391
-30.0%
0.00%
Q2 2019$23,000
-43.9%
3,416
-30.7%
0.00%
Q1 2019$41,000
+215.4%
4,932
+106.3%
0.00%
Q4 2018$13,000
-79.0%
2,391
-65.8%
0.00%
Q3 2018$62,000
+138.5%
6,983
+126.9%
0.00%
Q2 2018$26,000
+85.7%
3,078
+13.1%
0.00%
Q1 2018$14,000
+40.0%
2,721
+36.0%
0.00%
Q4 2017$10,000
-54.5%
2,0000.0%0.00%
Q3 2017$22,000
+15.8%
2,000
-8.6%
0.00%
Q2 2017$19,000
-52.5%
2,187
-47.7%
0.00%
Q1 2017$40,000
+90.5%
4,183
+109.2%
0.00%
Q4 2016$21,000
-25.0%
2,0000.0%0.00%
Q3 2016$28,000
+27.3%
2,0000.0%0.00%
Q2 2016$22,000
-12.0%
2,0000.0%0.00%
Q1 2016$25,000
-3.8%
2,0000.0%0.00%
Q4 2015$26,000
+36.8%
2,000
+33.3%
0.00%
Q3 2015$19,000
-52.5%
1,500
-33.9%
0.00%
Q2 2015$40,000
+263.6%
2,270
+191.8%
0.00%
Q1 2015$11,000
+120.0%
778
+121.7%
0.00%
Q4 2014$5,0003510.00%
Other shareholders
REDHILL BIOPHARMA LTD shareholders Q3 2022
NameSharesValueWeighting ↓
IFP Advisors, Inc 300$2,1750.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of REDHILL BIOPHARMA LTD shareholders